logo-loader
AIM:AGY

Allergy Therapeutics PLC

Receive alerts
Market:
AIM
Market Cap:
£74.11 m
Price
11.65 GBX
Change
-2.10%
52 weeks high
15.70
52 weeks low
8.00

In brief

We are a market leading, pioneering immunology business with specialist experience in the research and development of allergy treatments.

Deep dive We explore the investor case for growth companies

Snapshot

  • Profitable allergy specialist developing new inoculations
  • Strong revenue growth in Europe
  • Long pipeline of new products under development